Profile of Lung cancer in two Niger Delta States, Nigeria: Evaluation of 43 cases
Main Article Content
Keywords
Epidemiology, Environmental Pollutants, Lung Cancer Niger-Delta
Abstract
Background: The data on the epidemiology of lung cancer in Niger delta states is scarce. Therefore, this study aims to determine the epidemiological profile of lung cancer in two Niger Delta states in Nigeria.
Methodology: This was a retrospective analysis of all patients managed for histologically diagnosed lung cancer from Jan 2014 to Dec 2019 at two tertiary hospitals in the Niger Delta states of Nigeria. The demographics, diagnoses, results of investigations, and outcomes were analysed using descriptive statistics.
Results: Forty-three patients were reviewed with a male-to-female ratio of 1.5:1 and an age range between 13-89 years, with a mean of 53.5+17.0 years. The following number of patients; 1(2.3%), 26(60.5%), 4 (9.3%) and 12(27.9%) were distributed according into the following age groups ;< 20, 20-59, 60-64 and >65 respectively. Eleven (25.6%) patients were smokers. The commonest symptoms were dyspnoea in 39(90.7%), cough in 35(81.4%), weight loss in 29(67.4%), chest pain in 28(65.1%), and change in voice (hoarseness of voice) in 8(18.6%); while the signs were respiratory distress in 33(76.7%), digital clubbing in 8(18.6%), superior vena cava syndrome in 2(4.7%). The left lung was commonly affected in 24(55.8%) patients, and the left upper lobe was the most common in 21 (20.2%), while the right upper lobe was the least in 13(12.6%) patients. The histological types were Adenocarcinoma in 26(60.5%), squamous cell carcinoma in 15(34.9%) patients, and small cell carcinoma in 2(4.7%) patients. Fifteen (34.9%) patients had elevated platelets. The modalities of pathologic diagnoses were: Mini-Thoracotomy10 (23.3%), Tru-cut biopsy 28 (65.1%), and Bronchoscopy 5 (11.6%). The mortality rate after six months following lung cancer diagnosis was 7(16.2%).
Conclusion: In our environment, lung cancer may have a bimodal distribution, peaking in the middle age group and elderly patients who were mainly non-smokers. Elevation of platelets was observed in a significant number of patients.
References
2.Cohen AJ. Air pollution and lung cancer: what more do we need to know? Thorax.2003; 58:1010-1012. 3.Connellan SJ. Lung diseases associated with hydrocarbon. Resp Med. 2017; 126:46-51.
4.Hamra GB, Guha N, Cohen A, Laden F,Raaschou-Nielsen O, Samet JM, et al. Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis. Environ Health Perspect. 2014; 122:906-11.
5.Okoro EE, Ochonma C, Omeje M, Sanni SE, Emetere ME, Orodu KB, Igwilo KC. Radiological and toxicity risk exposures of oil-based mud: health implication on drilling crew in Niger Delta. Environ SciPollut Res Int. 2020; 27:5387-5397.
6.GLOBOCAN.International Agency for Research in Cancer; 2020. Available from: https://www.gco.iarc.fr/today/data/factsheets/ populations/566-Nigeria-fact-sheets.pdf. [Last accessed on 2021 Mar 21].
7.Centre for Disease Control and Prevention. Lung Cancer Among People Who Never Smoked.https://www.cdc.gov/cancer/lung/non smokers/index.html[Last Accessed on 2021Mar 21]
8.Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F. International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilising in men but still increasing in women. Lung Cancer. 2014; 84: 13–22.
9.Papadopoulos A, Guida F, Leffondré K, Cénée S, Cyr D, Schmaus A, etal.Heavy smoking and lung cancer: are women at higher risk? Result of the ICARE study. Br J Cancer. 2014 4; 110:1385-91.
10.Zang EA, Wynder EL. Differences in lung cancer risk between men and women: anexamination of the evidence. J Natl Cancer Inst. 1996; 88:183-92.
11. Ana GREE, Sridhar MKC, Asuzu MC. Environmental risk factors and hospital-based cancers in two Nigerian cities. J Public Health Epid 2010; 2:216-223.
12.North CM, Christiani DC. Women and lung cancer: what is new? SeminThoracCardiovasc Surg. 2013 summer; 25:87-94.
13.Christopher OC, Charles NC. Cancer mortality in the Niger Delta region of Nigeria:A case study of the University of PortHarcourt teaching hospital. Niger Med J2019; 60:268-72.
14.Barrera-Rodriguez R, Morales-Fuentes J. Lung cancer in women. Lung Cancer (Auckl).2012; 15; 3:79-89.
15. WHO age group classification 2022.https://www.google.com/search?source =univ&tbm=isch&q=who+age+group+classif ication+2022&fir=FOBUgH7VFgkpvM%252 C9hNGqCnF5pB-7M%25. [Last accessed on 2022 Oct 11].
16.Okonta KE, Ofori SN, Agugua CC, Osademe P. Non-image-guided true-cut biopsy of lung masses in adult Nigerians in a limited-resource setting. Niger J Cardiovasc Thorac Surg. 2020;5:34-7
17. WHO. Cancer Today https://gco.iarc.fr/today/data/factsheets/cancer s/15-Lung-fact-sheet.pdf. [Last accessed on 2022 April 11].
18.Laryea DO, Awuah B, Amoako YA, Osei-Bonsu E, Dogbe J, Larsen-Reindorf R, et al. Cancer incidence in Ghana, 2012: Evidence from a population-based cancer registry. BMC Cancer 2014; 14:362.
19.British Lung Foundation. Lung disease in the UK. Lung cancer statistics. Available from: https://www.statistics.blf.org.uk/statistics/ lung-cancer. [Last accessed on 2021 Mar 21].
20.Ogunbiyi JO. Lung cancer at the University College Hospital, Ibadan, Nigeria. West Afr J Med. 1995; 14:50-5.
21.Ezemba N, Ekpe EE, Eze JC. Challenges of lung cancer management in a developing country. Niger J Med. 2012; 21:214-7.
22.Adeoye PO, Desalu OO, Ofoegbu CKP, Fawibe AE, Salami AK, Akanbi OR, et al. Clinicopathological Pattern and Management of Primary Lung Cancer in Ilorin, Nigeria. West Afr J Med. 2021; 38:380-386.
23.Walker AR, Walker BF. Lung cancer in Africans in a South African city population in transition. Eur J Cancer Prev. 2005; 14:187-9.
24.Tamási L, Horváth K, Kiss Z, Bogos K, Ostoros G, Müller V, et al. Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016. Pathol Oncol Res. 2021; 27:598862. doi:10.3389/pore.2021.598862.
25.Guarga L, Ameijide A, Marcos-Gragera R, Carulla M, Delgadillo J, Borràs JM, Galceran J. Trends in lung cancer incidence by age, sex and histology from 2012 to 2025 in Catalonia (Spain). Sci Rep. 2021; 11:23274. doi: 10.1038/s41598-021-02582-8.
26. American Cancer Society. About Lung Cancer. Key Statistics for Lung Cancer.
https://www.cancer.org/cancer/lung- cancer/about/key–statistics.html[Last accessed on 2021 April 10]
27.Inamura K. Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification. Front Oncol.2017;
28; 7:193.doi: 10.3389/fonc.2017.00193. 28.Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer. 2001; 31:139-48.
29.Sahmoun AE, Case LD, Santoro TJ, Schwartz GG. Anatomical distribution of small cell lungcancer: effects of lobe and gender on brain metastasis and survival. Anticancer Res. 2005; 25:1101-8.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.
Kelechi E. Okonta, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria
Reader, Department of Surgery, University of Port Harcourt, Port Harcourt, Nigeria